The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in Italy

Bibliography

• Permala J, Hassali MA, Awaisu A, et al. Dosing information in a standard drug reference: are pediatrics still therapeutically neglected? Pediatr Int 2010;52:290-5
   PubMed Web of Science ®Google Scholar
• Tan E, Cranswick NE, Rayner CR, et al. Dosing information for pediatric patients: are they really “therapeutic orphans”? Med J Aust 2003;179:195-8
   PubMed Web of Science ®Google Scholar
• Kimland E, Odlind V. Off-label drug use in pediatric patients. Clin Pharmacol Ther 2012;91:796-801
   PubMed Web of Science ®Google Scholar
• Carnovale C, Conti V, Perrone V, et al. Pediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches. Eur J Pediatr 2013;172(12):1679-85
   PubMed Web of Science ®Google Scholar
• Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in pediatric outpatients. Br J Clin Pharmacol 2002;54:665-70
   PubMed Web of Science ®Google Scholar
• Junker A, Klassen K. Improving standards for paediatric clinical trials. Paediatr Child Health 2011;16:539-40
   PubMed Web of Science ®Google Scholar
• Carnovale C, Pozzi M, Nisic AA, et al. Sleep disruption and proprioceptive delirium due to acetaminophen in a pediatric patient. Case Rep Pediatr 2013;2013:471294
   PubMedGoogle Scholar
• Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129131.pdf [Last accessed 19 May 2014]
   Google Scholar
• Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharacol Ther 1981;30:239-45
   PubMed Web of Science ®Google Scholar
• The use of the WHO–UMC system for standardised case causality assessment. Available from: http://who-umc.org/Graphics/24734.pdf [Last accessed 7 February 2014]
   Google Scholar
• Loughlin AM, Marchant CD, Adams W, et al. Causality assessment of adverse events reported to the vaccine adverse event reporting system (VAERS). Vaccine 2012;30:7253-9
   PubMed Web of Science ®Google Scholar
• Collet JP, MacDonald N, Cashman N, et al. Monitoring signals of vaccine safety: the assessment of individual adverse events reports by and expert advisory panel. Bull World Health Organ 2000;78(2):178-85
   PubMed Web of Science ®Google Scholar
• Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf 1999;109-11
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. ICH topic E 11. Clinical investigation of medicinal products in the pediatric population. 2001. CPMP/ICH/2711/99 [online] Available from: http://www.ema.europa.eu/pdfs/human/ich/271199en.pdf [Last accessed 7 Feb 2014]
   Google Scholar
• ICH E2A guideline: note for guidance on clinical safety data management: definitions and standards for expedited reporting. Available from: http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html
   Google Scholar
• Neubert A, Wong IC, Bonifazi A, et al. Defining off-label and unlicensed use of medicines for children: results of a Delphi survey. Pharmacol Res 2008;58:316-22
   PubMed Web of Science ®Google Scholar
• Hazell L, Shakir SA. Underreporting of adverse drug reactions: a systematic review. Drug Saf 2006;29:385-96
   PubMed Web of Science ®Google Scholar
• Kimland E, Rane A, Ufer M, et al. Pediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol Drug Saf 2005;14:493-9
   PubMed Web of Science ®Google Scholar
• Raucci U, Rossi R. Da Cas R, at al. Stevens-Johnson syndrome associated with drugs and vaccines in children: a case-control study. PLoS One 2013;8:e68231
   PubMed Web of Science ®Google Scholar
• Bianciotto M, Chiappini E, Raffaldi I, et al. Drug use and upper gastrointestinal complications in children: a case-control study. Arch Dis Child 2013;98:218-21
   PubMed Web of Science ®Google Scholar
• Bertuola F, Morando C, Menniti-Ippolito F, et al. Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy. Drug Saf 2010;33:65-72
   PubMed Web of Science ®Google Scholar
• Neubert A, Dormann H, Weiss J, et al. The impact of unlicensed and off-label drug use on adverse drug reactions in pediatric patients. Drug Saf 2004;27:1059-67
   PubMed Web of Science ®Google Scholar
• Smyth RM, Gargon E, Kirkham J, et al. Adverse drug reactions in children–a systematic review. PLoS One 2012;7:e24061
   PubMed Web of Science ®Google Scholar
• Aldea A, García Sánchez-Colomer M, Fernández Quintana E, et al. Pediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009. Eur J Clin Pharmacol 2012;68:1329-38
   PubMed Web of Science ®Google Scholar
• Aagaard L, Weber CB, Hansen EH. Adverse drug reactions in the pediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf 2010;33:327-39
   PubMed Web of Science ®Google Scholar
• Star K, Norén GN, Nordin K, et al. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf 2011;34:415-28
   PubMed Web of Science ®Google Scholar
• Buajordet I, Wesenberg F, Brors O, et al. Adverse drug events in children during hospitalization and after discharge in a Norwegian university hospital. Acta Paediatr 2002;91:88-94
   PubMed Web of Science ®Google Scholar
• Li H, Guo XJ, Ye XF, et al. Adverse drug reactions of spontaneous reports in shanghai pediatric population. PLoS One 2014;9:e89829
   PubMed Web of Science ®Google Scholar
• Pellegrino P, Carnovale C, Perrone V, et al. Can HPV immunisation cause ADEM? Two case reports and literature review. Mult Scler 2013;20(6):762-3
   Google Scholar
• Pellegrino P, Carnovale C, Pozzi M, et al. On the relationship between human papilloma virus vaccine and autoimmune diseases. Autoimmun Rev 2014;24:S1568-9972
   Google Scholar
• Pellegrino P, Carnovale C, Perrone V, et al. Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems. PLoS One 2013;8:e77766
   PubMedGoogle Scholar
• Carnovale C, Pellegrino P, Beretta S, et al. A case of tinnitus induced by chlorpromazine in a pediatric patient. J Pharmacol Pharmacother 2014;5(2):163-5
   Google Scholar
• Pozzi M, Strazzer S, Locatelli F, et al. Case series: paradoxical action of domperidone leads to increased vomiting. Eur J Clin Pharmacol 2013;69(2):289-90
   PubMed Web of Science ®Google Scholar
• Carleton BC, Smith MA, Gelin MN, et al. Pediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol 2007;14(1):45-57
   PubMedGoogle Scholar
• Ruggiero S, Di Nardo R, Polimeno T, et al. Ceftriaxone-induced pancreatitis in a pediatric patient: case report. J Chemother 2010;22:63-5
   PubMed Web of Science ®Google Scholar
• Raucci U, Rossi R, Da Cas R, et al. Stevens-Johnson syndrome associated with drugs and vaccines in children: a case-control study. PLoS One 2013;8:e68231
   PubMed Web of Science ®Google Scholar
• Bianciotto M, Chiappini E, Raffaldi I, et al. Drug use and upper gastrointestinal complications in children: a case-control study. Arch Dis Child 2013;98:218-21
   PubMed Web of Science ®Google Scholar
• Bertuola F, Morando C, Menniti-Ippolito F, et al. Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy. Drug Saf 2010;33:65-72
   PubMed Web of Science ®Google Scholar
• Alfonsi V, D’Ancona F, Rota MC, et al. Immunisation registers in Italy: a patchwork of computerisation. Eurosurveillance 2012;17(17), pii: 20156
   Web of Science ®Google Scholar
• Aagaard L, Christensen A, Hansen EH. Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol 2010;70:481-91
   PubMed Web of Science ®Google Scholar
• Ruggiero S, Rafaniello C, Bravaccio C, et al. Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study. J Child Adolesc Psychopharmacol 2012;22:415-22
   PubMed Web of Science ®Google Scholar
• Clavenna A, Rossi E, De Rosa M, et al. Use of psychotropic medications in Italian children and adolescents. Eur J Pediatr 2007;166:339-47
   PubMed Web of Science ®Google Scholar
• Pozzi M, Bertella S, Cattaneo D, et al. Are non-serious adverse reactions to psychiatric drugs really non-serious? J Child Adolesc Psychopharmacol 2013;23:394-400
   PubMed Web of Science ®Google Scholar
• Star K, Edwards IR. Pharmacovigilance for children’s sake. Drug Saf 2014;37:91-8s
   PubMed Web of Science ®Google Scholar